Barostim is the first FDA-approved technology that uses neuromodulation to improve heart failure symptoms.
5 months ago

St. Jude Medical, Inc. has announced the U.S. launch and first post-approval implants of the St. Jude Medical Axium Neurostimulator System...
102 months ago

Let's examine the effects of BPO firms in Hyderabad and how their presence impacts the dynamics of the real estate market in the city.
11 months ago

The new technology add-on payment (NTAP) program is a payment system designed by Congress to encourage the uptake of new and costly medical...
67 months ago

FDA approved Abbott's neuromodulation treatment platform to allows physicians to monitor or change patients' treatment in real-time.
43 months ago

This surge, representing approximately 6% of its workforce, is attributed to acquiring new clients and expanding several ongoing contracts.
13 months ago